May 22, 2:38 PM EDT
Media & Culture
U.S. panel backs Boehringer drug to reduce strokes
By IBT Staff Reporter on 09/21/10 AT 9:53 AM
A new blood-thinning drug moved closer to U.S. approval on Monday, leading a pack of stroke-fighting medicines vying to compete in an estimated $10 billion a year market.